Omkar Speciality Chemicals is currently trading at Rs. 173.85, up by 8.80 points or 5.33% from its previous closing of Rs. 165.05 on the BSE.
The scrip opened at Rs. 170.20 and has touched a high and low of Rs. 176.00 and Rs. 170.20 respectively. So far 26,000 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 249.10 on 13-Jan-2016 and a 52 week low of Rs. 137.50 on 28-Jul-2016.
Last one week high and low of the scrip stood at Rs. 176.00 and Rs. 161.20 respectively. The current market cap of the company is Rs. 356.72 crore.
The promoters holding in the company stood at 56.18%, while Institutions and Non-Institutions held 7.98% and 35.84% respectively.
Omkar Speciality Chemicals, one of the leading players in the manufacturing of Speciality Chemicals and Veterinary APIs, has obtained a patent related to the ‘Process for Manufacturing 2-Hydroxy-3,5- Diiodobenzoic Acid’ granted by the Government of India. The process is safe, simple, economic and eco-friendly.
The company has stated that this patent is certainly a biggest achievement as it is granted after validating the strong technicalities and the high economic significance of this process. The Controller of Patents has prominently noted these finding in his Grant Decision. With this, the total number of patents, till date, granted to the company stands at 3.
Omkar Speciality Chemicals is primarily engaged in the production of Speciality Chemicals and Pharma Intermediates. The company manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates.